Impact of Risk-Benefit Perception and Trust on Medical Technology Acceptance in Relation to Drug and Device Lag: A Tripartite Cross-Sectional Survey
Authors:
- 1 September 2018
- journal article
- research article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 52 (5) , 629-640
Abstract
New drug and medical device introduction in Japan usually lags behind that in the West. Many reports indicate that in Japan, the associated risks are consiKeywords
Funding Information
- Ministry of Health, Labour and Welfare (Health Labour Sciences Research Grant (Japan), res)
This publication has 29 references indexed in Scilit:
- HPV vaccination programme in JapanThe Lancet, 2013
- Current issues with the immunization program in Japan: Can we fill the “vaccine gap”?Vaccine, 2012
- Consumers' Understanding and Concerns About Bovine Spongiform Encephalopathy (BSE): Comparison Among Canadian, American, and Japanese ConsumersJournal of Toxicology and Environmental Health, Part A, 2011
- Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicinesInternational Journal of Clinical Oncology, 2011
- Environmental radiation: Risk benchmarks or benchmarking risk assessmentIntegrated Environmental Assessment and Management, 2011
- Cross-Cultural Differences in Risk Perceptions of DisastersRisk Analysis, 2010
- Sunbed Use in German Adults: Risk Awareness Does Not Correlate With BehaviourActa Dermato-Venereologica, 2009
- Definition of the Device Lag and Its MeasurementIryou kikigaku (The Japanese journal of medical instrumentation), 2009
- Japanese Public Perceptions of Food‐Related HazardsJournal of Risk Research, 2007
- First U.S. Case of Mad Cow Sharpens Debate Over TestingScience, 2004